Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-02-01 Sale |
2021-02-03 5:37 pm |
Coherus BioSciences Inc. | CHRS | Viret Jean-Frederic Chief Financial Officer |
7,402 | $21.55 | $159,513 | 115,462 (Direct) |
View |
2021-01-25 Sale |
2021-01-27 4:15 pm |
Coherus BioSciences Inc. | CHRS | Viret Jean-Frederic Chief Financial Officer |
46,144 | $19.95 | $920,736 | 122,864 (Direct) |
View |
2020-11-17 Sale |
2020-11-19 4:16 pm |
Coherus BioSciences Inc. | CHRS | Viret Jean-Frederic Chief Financial Officer |
1,995 | $17.49 | $34,896 | 150,510 (Direct) |
View |
2020-10-14 Sale |
2020-10-16 4:19 pm |
Coherus BioSciences Inc. | CHRS | Viret Jean-Frederic Chief Financial Officer |
6,144 | $19 | $116,736 | 40,423 (Direct) |
View |
2020-05-20 Sale |
2020-05-22 4:30 pm |
Coherus BioSciences Inc. | CHRS | Viret Jean-Frederic Chief Financial Officer |
1,278 | $17.66 | $22,569 | 46,567 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-04-05 Equity Swap |
2024-04-08 4:14 pm |
N/A N/A |
NGM BIOPHARMACEUTICALS INC | NGM | Viret Jean-Frederic Chief Financial Officer |
3,038 | $0 | 0 (Direct) |
View |
2023-12-01 Option Award |
2023-12-04 4:27 pm |
N/A 2033-11-30 |
NGM BIOPHARMACEUTICALS INC | NGM | Viret Jean-Frederic Chief Financial Officer |
450,000 | $0 | 450,000 (Direct) |
View |
Ownership |
2023-11-08 6:13 pm |
N/A N/A |
NGM BIOPHARMACEUTICALS INC | NGM | Viret Jean-Frederic Chief Financial Officer |
0 | $0 | 38 (Direct) |
View |
2021-02-01 Exercise |
2021-02-03 5:37 pm |
N/A 2028-02-01 |
Coherus BioSciences Inc. | CHRS | Viret Jean-Frederic Chief Financial Officer |
7,402 | $0 | 115,462 (Direct) |
View |
2021-02-01 Exercise |
2021-02-03 5:37 pm |
N/A N/A |
Coherus BioSciences Inc. | CHRS | Viret Jean-Frederic Chief Financial Officer |
7,402 | $10.05 | 115,462 (Direct) |
View |
2021-01-25 Exercise |
2021-01-27 4:15 pm |
N/A 2028-02-01 |
Coherus BioSciences Inc. | CHRS | Viret Jean-Frederic Chief Financial Officer |
40,000 | $0 | 122,864 (Direct) |
View |
2021-01-25 Exercise |
2021-01-27 4:15 pm |
N/A N/A |
Coherus BioSciences Inc. | CHRS | Viret Jean-Frederic Chief Financial Officer |
40,000 | $10.05 | 122,864 (Direct) |
View |
2021-01-11 Option Award |
2021-01-13 4:23 pm |
N/A 2031-01-11 |
Coherus BioSciences Inc. | CHRS | Viret Jean-Frederic Chief Financial Officer |
93,750 | $0 | 129,939 (Direct) |
View |
2021-01-10 Tax Withholding |
2021-01-12 4:55 pm |
N/A N/A |
Coherus BioSciences Inc. | CHRS | Viret Jean-Frederic Chief Financial Officer |
4,080 | $18.18 | 36,189 (Direct) |
View |
2020-11-17 Exercise |
2020-11-19 4:16 pm |
N/A 2024-11-05 |
Coherus BioSciences Inc. | CHRS | Viret Jean-Frederic Chief Financial Officer |
1,500 | $0 | 150,510 (Direct) |
View |
2020-11-17 Exercise |
2020-11-19 4:16 pm |
N/A N/A |
Coherus BioSciences Inc. | CHRS | Viret Jean-Frederic Chief Financial Officer |
1,500 | $13.5 | 150,510 (Direct) |
View |